SCHEMBL31018737

SCHEMBL31018737

CCOCc1ncc([N+](=O)[O-])n1C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.63
▸ CYP2C19 P33261 1/20 0.50
▸ MAPK1 P28482 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ THRB P10828 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ CA1 P00915 5/20 0.38
▸ CA2 P00918 5/20 0.38
▸ CA9 Q16790 5/20 0.38
▸ CA12 O43570 4/20 0.38
▸ GLA P06280 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ ATM Q13315 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15752503 0.92 LMNA (0.68) LMNACYP2C19MAPK1ALDH1A1THRB
SCHEMBL31018741 0.88 LMNA (0.60) LMNACYP2C19MAPK1ALDH1A1THRB
SCHEMBL17172711 0.85 LMNA (0.60) LMNACYP2C19MAPK1ALDH1A1THRB
SCHEMBL31018740 0.84 LMNA (0.67) LMNACYP2C19MAPK1ALDH1A1THRB
SCHEMBL31018738 0.84 LMNA (0.67) LMNACYP2C19MAPK1ALDH1A1THRB
SCHEMBL11856721 0.82 LMNA (0.59) LMNACYP2C19MAPK1ALDH1A1THRB
SCHEMBL15752460 0.79 LMNA (0.60) LMNACYP2C19MAPK1ALDH1A1THRB
SCHEMBL11735334 0.79 LMNA (0.77) LMNACYP2C19MAPK1ALDH1A1THRB
SCHEMBL4873214 0.78 LMNA (0.75) LMNACYP2C19MAPK1ALDH1A1THRB
Ronidazole SCHEMBL635714 0.78 LMNA (1.00) LMNACYP2C19MAPK1ALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4655286-A2 COMPOUNDS AND THEIR USE IN THE TREATMENT OF NON-VIRAL DISEASES AND INFECTIONS Technische Universität München, in Vertretung des Freistaats Bayern (DE) 2025-12-03 — — EP disclosed
WO-2024156883-A2 COMPOUNDS AND THEIR USE IN THE TREATMENT OF NON-VIRAL DISEASES AND INFECTIONS Technische Universität München (DE) 2024-08-02 — — WO disclosed
Send feedback